Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9518 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9515 |
High Similarity |
NPD6797 |
Phase 2 |
0.9458 |
High Similarity |
NPD7251 |
Discontinued |
0.9286 |
High Similarity |
NPD7808 |
Phase 3 |
0.9277 |
High Similarity |
NPD7054 |
Approved |
0.9222 |
High Similarity |
NPD7472 |
Approved |
0.9107 |
High Similarity |
NPD7074 |
Phase 3 |
0.9102 |
High Similarity |
NPD3818 |
Discontinued |
0.9096 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9096 |
High Similarity |
NPD6166 |
Phase 2 |
0.9096 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.908 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8935 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8902 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8841 |
High Similarity |
NPD3817 |
Phase 2 |
0.883 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD7075 |
Discontinued |
0.8614 |
High Similarity |
NPD5402 |
Approved |
0.8606 |
High Similarity |
NPD1934 |
Approved |
0.858 |
High Similarity |
NPD1512 |
Approved |
0.8563 |
High Similarity |
NPD3882 |
Suspended |
0.8554 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD5403 |
Approved |
0.8494 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8443 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8443 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8405 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8344 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8229 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8182 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8156 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8156 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8103 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8057 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8011 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7975 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7944 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7943 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7906 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7869 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD919 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7803 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7795 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7758 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7749 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7714 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7644 |
Intermediate Similarity |
NPD37 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7561 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.756 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7538 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7513 |
Intermediate Similarity |
NPD7584 |
Approved |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.75 |
Intermediate Similarity |
NPD8319 |
Approved |
0.75 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7487 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7475 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7447 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD3748 |
Approved |
0.741 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.73 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD920 |
Approved |
0.725 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7241 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7178 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7077 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7 |
Intermediate Similarity |
NPD7038 |
Approved |
0.6994 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD5353 |
Approved |
0.6973 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6964 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6954 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6954 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD2800 |
Approved |
0.6954 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6941 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD2344 |
Approved |
0.6933 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2798 |
Approved |
0.6923 |
Remote Similarity |
NPD4287 |
Approved |
0.6909 |
Remote Similarity |
NPD3225 |
Approved |
0.6898 |
Remote Similarity |
NPD5242 |
Approved |
0.689 |
Remote Similarity |
NPD9717 |
Approved |
0.6886 |
Remote Similarity |
NPD9494 |
Approved |
0.6885 |
Remote Similarity |
NPD4288 |
Approved |
0.6882 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD6100 |
Approved |
0.6879 |
Remote Similarity |
NPD5406 |
Approved |
0.6879 |
Remote Similarity |
NPD5404 |
Approved |
0.6879 |
Remote Similarity |
NPD6099 |
Approved |
0.6879 |
Remote Similarity |
NPD5405 |
Approved |
0.6879
|
Remote Similarity |
NPD5408 |
Approved |